BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2227595)

  • 1. Epithelial ovarian tumors of borderline malignancy.
    Rice LW; Berkowitz RS; Mark SD; Yavner DL; Lage JM
    Gynecol Oncol; 1990 Nov; 39(2):195-8. PubMed ID: 2227595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases.
    Bostwick DG; Tazelaar HD; Ballon SC; Hendrickson MR; Kempson RL
    Cancer; 1986 Nov; 58(9):2052-65. PubMed ID: 3756820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial ovarian tumors of borderline malignancy.
    Chao TM; Yen MS; Chao KC; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative treatment of borderline ovarian tumors.
    Tazelaar HD; Bostwick DG; Ballon SC; Hendrickson MR; Kempson RL
    Obstet Gynecol; 1985 Sep; 66(3):417-22. PubMed ID: 4022501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline ovarian tumors.
    Chambers JT; Merino MJ; Kohorn EI; Schwartz PE
    Am J Obstet Gynecol; 1988 Nov; 159(5):1088-94. PubMed ID: 3189441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of 27 ovarian tumors of low malignant potential.
    Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
    Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
    Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic restaging of borderline ovarian tumors.
    Daraï E; Tulpin L; Prugnolle H; Cortez A; Dubernard G
    Surg Endosc; 2007 Nov; 21(11):2039-43. PubMed ID: 17514402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum CA-125 levels in borderline tumors of the ovary.
    Rice LW; Lage JM; Berkowitz RS; Goodman A; Muto MG; Knapp RC; Bell DA
    Gynecol Oncol; 1992 Aug; 46(2):226-9. PubMed ID: 1500026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004.
    Wong HF; Low JJ; Chua Y; Busmanis I; Tay EH; Ho TH
    Int J Gynecol Cancer; 2007; 17(2):342-9. PubMed ID: 17343573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
    Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
    Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage I epithelial ovarian tumors of low malignant potential.
    Sawada M; Yamasaki M; Urabe T; Hashimoto K; Katayama S
    Jpn J Clin Oncol; 1991 Feb; 21(1):30-4. PubMed ID: 2067119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low value of staging in detecting extraovarian occult metastasis in mucinous borderline ovarian tumors.
    Jung HJ; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2020 Nov; 30(11):1780-1783. PubMed ID: 32928923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical proliferative endometrioid tumor of ovary: Report of a rare case.
    Jetley S; Khetrapal S; Ahmad A; Jairajpuri ZS
    J Postgrad Med; 2016; 62(2):129-32. PubMed ID: 26497398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland.
    Kumpulainen S; Kuoppala T; Leminen A; Komulainen M; Puistola U; Sankila R; Mäkinen J; Grénman S
    Acta Obstet Gynecol Scand; 2007; 86(5):610-4. PubMed ID: 17464592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.